More specifically, the amyloid-β 42/40 ratio and amyloid-β 42/total tau ratio are considered to be strong predictors of AD progression.23 Therefore we focus on the group of MCI patients and relate their ratios to patient-related risk factors for dementia. This evidence concerns the gene MAPT and dementia.